{"retracted":false,"update":{"timestamp":1438041600000,"doi":"10.1007/s12325-015-0230-4","type":"correction"},"doi":"10.1007/s12325-015-0224-2","journal":"Advances in Therapy","publisher":"Springer Nature","title":"Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study"}
